Samsun Liv Hospital赞助的临床试验
总计954个结果
-
Lei Li招聘中复发性宫颈癌 | 放疗 | 免疫疗法 | 生存结果 | 免疫检查点抑制剂 | 客观反应率 | 转移性宫颈癌 | 替雷利珠单抗 | 持续性宫颈癌 | 抗程序性细胞死亡受体 1中国
-
Lei Li招聘中
-
Lei Li未知
-
Lei Li未知上皮性卵巢癌 | 代谢组学 | 转录组学 | 全外显子组测序 | Tumor Invasiveness | Tumorigenesis中国
-
Samsung Medical CenterAsan Medical Center; Korea University Anam Hospital; Gyeongsang National University Hospital完全的
-
Lei Li招聘中
-
Lv Yingjuan完全的
-
Lv YingjuanTianjin Medical University Eye Hospital完全的
-
Zheng Liu ENTZhongnan Hospital; Wuhan Union Hospital, China; The People's Hospital of Hebei Province招聘中
-
Seoul National University HospitalSamsung Medical Center; Chung-Ang University Hosptial, Chung-Ang University College of Medicine 和其他合作者完全的
-
Samsung Medical CenterAsan Medical Center; Konkuk University Medical Center; Severance Hospital招聘中
-
Samsung Medical CenterNational Cancer Center, Korea; Asan Medical Center; Severance Hospital完全的
-
Samsung Medical CenterSeoul National University Hospital; Gachon University Gil Medical Center未知
-
Lei Li招聘中复发性宫颈癌 | 放疗 | 免疫检查点抑制剂 | 总生存期 | 抗程序性死亡-1 抗体 | 转移性宫颈癌 | 持续性晚期宫颈癌 | 客观缓解率 | 无进展生存期 | 严重不良事件中国
-
Lei Li招聘中